PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1477102
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1477102
Bioactive Coating Devices Market size was valued at USD 1,548.34 Million in 2023, expanding at a CAGR of 8.9% from 2024 to 2032.
Medical devices can be enhanced using bioactive coatings, which are thin layers that provide bioactivity and biocompatibility, enhance core performance, and inhibit bacterial adhesion. This phrase is most frequently associated with medical devices that are implanted. Bioceramics, ECM proteins, biological peptides, growth factors, and antimicrobial peptides are examples of bioactive coatings.
Bioactive Coating Devices Market- Market Dynamics
Improvement in drug loading and delivery to propel market demand
Bioactive molecular thin-film implants are becoming increasingly popular for the treatment of orthopaedic joint issues and cardiology, which are currently the two main sources of disability and loss of quality of life. To enhance drug loading and delivery, bioactive molecules are being used to load and release a multitude of material-bound components.
Bioactive Coating Devices Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.9% over the forecast period (2024-2032)
Based on product type, the Drug Eluting Coating segment is expected to grow at the highest CAGR during the forecast period
Based on the material segmentation, the Biological Materials segment is expected to grow significantly over the forecast period
Based on end user segmentation, the hospital segment is expected to lead the market over the projected period
Based on region, North America was the leading revenue generator in 2023
The Global Bioactive Coating Devices Market is segmented based on Product Type, Material, End User, and Region.
Based on the product type, the market is categorized into Drug Eluting Coating, Anti-Microbial Coatings and Hydrophilic Coatings. The Drug Eluting Coating segment is expected to grow at the highest CAGR during the forecast period. When it comes to treating native coronary artery constriction and other conditions (such as anti-thrombogenic coatings), they are statistically better than bare-metal stents.
Based on the material, the market is divided into Carbon-Based Materials, Biological Materials, Metals and Alloys and Polymers and Synthetic. The Biological Materials segment is expected to grow significantly over the forecast period. The segment expansion is attributed to the rising investment and growing awareness.
Based on the end user, the industry is divided into Diagnostics Centers, Hospital, Ambulatory Surgical Centers and Clinics. The Hospital segment is expected to lead the market over the projected period because modern healthcare facilities and surgical instruments are necessary.
Bioactive Coating Devices Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The area is a center for materials science and medical technology research and development. Continuous improvements in manufacturing techniques and material science led to the creation of new, improved-property biocompatible coatings, which propels market growth even further.
The key players operating in the market include Advansource Biomaterials Corporation, Aculon, Inc., Applied Membrane Technology, AST Products, Inc., Biocoat Incorporated, Biointeractions Limited, Applied Medical Coatings, Coatings2Go, Formacoat, LLC, Endura Coatings, DSM Biomedical, Freudenberg Medical, Covalon Technologies Ltd., Harland Medical Systems, Lincotek Medical, Miller-Stephenson, Poly-Med, Inc., Precision Coating Company, Inc., Specialty Coating Systems, Inc., Hemoteq AG and Surmodics, Inc. These players adopted several strategies to capture the maximum market share such as product launch, acquisition, expansion and others.
GLOBAL BIOACTIVE COATING DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
BioInteractions Ltd.
AST Products, Inc.
Bruker Corporation
Carmeda AB
Harland Medical Systems, Inc.
Biocoat Incorporated
Hexacath Company
LipoCoat BV
OC Oerlikon Management AG
Himed LLC
implantcast GmbH
Panacol-Elosol GmbH
Picosun Oy by Applied Materials, Inc.
Royal DSM
Hydromer, Inc.